Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8222 |
Intermediate Similarity |
NPD4749 |
Approved |
0.8209 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.8188 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8188 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8116 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8092 |
Intermediate Similarity |
NPD6671 |
Approved |
0.8082 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.8 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7958 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7958 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7943 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7808 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7808 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7806 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7778 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.777 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7737 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7697 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7681 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7655 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7655 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7655 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7552 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7536 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7535 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7533 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7532 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7518 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7516 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7484 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7469 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7466 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7465 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7451 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7451 |
Intermediate Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7445 |
Intermediate Similarity |
NPD7644 |
Approved |
0.7439 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7429 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7405 |
Intermediate Similarity |
NPD37 |
Approved |
0.74 |
Intermediate Similarity |
NPD5762 |
Approved |
0.74 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7394 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7383 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7379 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7375 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7375 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7375 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7372 |
Intermediate Similarity |
NPD7340 |
Approved |
0.7368 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7368 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7361 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7358 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7333 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD7985 |
Registered |
0.7329 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7324 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7324 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD5402 |
Approved |
0.731 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7301 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7286 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1398 |
Phase 1 |
0.7278 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7259 |
Intermediate Similarity |
NPD228 |
Approved |
0.7254 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7254 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7246 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7241 |
Intermediate Similarity |
NPD2237 |
Approved |
0.7237 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7206 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7202 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7202 |
Intermediate Similarity |
NPD7472 |
Approved |
0.719 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7186 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7186 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7179 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7152 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7117 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7095 |
Intermediate Similarity |
NPD411 |
Approved |
0.7092 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7083 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7073 |
Intermediate Similarity |
NPD919 |
Approved |
0.707 |
Intermediate Similarity |
NPD2532 |
Approved |
0.707 |
Intermediate Similarity |
NPD2534 |
Approved |
0.707 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7068 |
Intermediate Similarity |
NPD9697 |
Approved |
0.7067 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7067 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7063 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7047 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7042 |
Intermediate Similarity |
NPD17 |
Approved |
0.7039 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7037 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7032 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.703 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7019 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7015 |
Intermediate Similarity |
NPD968 |
Approved |
0.7014 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7014 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.6988 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6987 |
Remote Similarity |
NPD2219 |
Phase 1 |
0.6986 |
Remote Similarity |
NPD3266 |
Approved |
0.6986 |
Remote Similarity |
NPD3267 |
Approved |
0.6986 |
Remote Similarity |
NPD1203 |
Approved |
0.6981 |
Remote Similarity |
NPD5403 |
Approved |
0.6981 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6974 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.697 |
Remote Similarity |
NPD940 |
Approved |
0.697 |
Remote Similarity |
NPD846 |
Approved |
0.6968 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6963 |
Remote Similarity |
NPD290 |
Approved |
0.6962 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.6959 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD4675 |
Approved |
0.6957 |
Remote Similarity |
NPD7843 |
Approved |
0.6957 |
Remote Similarity |
NPD4678 |
Approved |
0.6951 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6948 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6948 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6948 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6948 |
Remote Similarity |
NPD1375 |
Discontinued |
0.6948 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6929 |
Remote Similarity |
NPD7157 |
Approved |
0.6928 |
Remote Similarity |
NPD6746 |
Phase 2 |
0.6928 |
Remote Similarity |
NPD5677 |
Discontinued |
0.6923 |
Remote Similarity |
NPD7982 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6918 |
Remote Similarity |
NPD8651 |
Approved |
0.6918 |
Remote Similarity |
NPD2676 |
Approved |
0.6918 |
Remote Similarity |
NPD2675 |
Approved |
0.6912 |
Remote Similarity |
NPD2684 |
Approved |
0.6909 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD2653 |
Approved |
0.6908 |
Remote Similarity |
NPD1607 |
Approved |
0.6899 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6887 |
Remote Similarity |
NPD4140 |
Approved |
0.6886 |
Remote Similarity |
NPD1247 |
Approved |
0.6883 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6879 |
Remote Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD6190 |
Approved |
0.6871 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6867 |
Remote Similarity |
NPD1048 |
Approved |
0.6857 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6855 |
Remote Similarity |
NPD5401 |
Approved |
0.6853 |
Remote Similarity |
NPD5585 |
Approved |
0.6852 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6846 |
Remote Similarity |
NPD844 |
Approved |
0.6846 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6845 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6842 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6842 |
Remote Similarity |
NPD1933 |
Approved |
0.6839 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6839 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6836 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6835
|
Remote Similarity |
NPD6667 |
Approved |